AUS
NZ
UK
CA
USA
IND
Healthcare
ASX Healthcare Leaders Draw ASX 200 Market Attention
June 05, 2026 04:37 PM AEST| By SamASX healthcare activity remains shaped by Telix Pharmaceuticals, Pro Medicus and Sigma Healthcare across diagnostics, imaging software and pharmacy distribution.
CSL’s ASX 200 Shake-Up Draws Attention Across Healthcare
June 05, 2026 04:37 PM AEST| By SamCSL’s planned Seqirus separation and Sigma Healthcare’s integration activities highlight a period of significant transformation across Australia’s healthcare sector, with companies refining operational focus and strategic direction.
Alterity Reshapes Capital Structure as Phase 3 Ambitions Take Centre Stage
June 05, 2026 11:10 AM AEST| By SamAlterity Therapeutics has streamlined its capital structure as it continues advancing its lead neurodegenerative disease program toward a major clinical milestone.
ASX Healthcare Outlook on ASX 100 Amid GLP-1 Debate
June 04, 2026 05:32 PM AEST| By SamGLP-1 therapies reshaped healthcare discussions, while companies such as ResMed, CSL and Cochlear continued operating across diverse medical markets and patient needs.
Healthcare Reset: ASX 100 Giants Under the Spotlight
June 04, 2026 05:32 PM AEST| By SamA detailed look at CSL, Cochlear and ResMed, highlighting healthcare industry trends, operational developments, demographic influences and evolving treatment landscapes worldwide.
Why Did ASX 200 Healthcare Face a Brutal Reset?
June 04, 2026 05:27 PM AEST| By SamASX healthcare’s reset placed CSL, Cochlear and ResMed in focus as valuation pressure, operational disruption and sentiment shifts reshaped the sector.
Can Careteq’s Board Refresh Accelerate Its AI Healthtech Ambitions?
June 04, 2026 11:20 AM AEST| By SamCareteq has appointed an experienced director as it continues developing AI-driven healthcare technology and pursuing commercial growth initiatives.
Can Microba’s Trading Halt Signal A Key Turning Point?
June 04, 2026 11:11 AM AEST| By SamMicroba Life Sciences has paused trading while preparing to announce funding plans and a business update, drawing attention to its microbiome health strategy and commercial progress.
Pro Medicus Lands Another Major US Win as Healthcare Demand Grows
June 04, 2026 10:08 AM AEST| By SamPro Medicus has secured another important US healthcare contract renewal, reinforcing its growing international presence and supporting continued adoption of enterprise imaging solutions.
Can ASX Healthcare on ASX 200 Mean Two Opposite Things?
June 03, 2026 02:00 PM AEST| By SamExplore the differences between established healthcare companies and biotechnology developers on the ASX, highlighting business models, innovation pathways and sector diversity.
Why Are ASX 200 Healthcare Leaders Facing Pressure?
June 03, 2026 01:59 PM AEST| By SamExplore the key healthcare companies shaping Australia's market, sector challenges, medical innovation trends, healthcare demand drivers and global industry developments.
Can ASX 200 Healthcare Leaders Balance Defence and Demand?
June 03, 2026 01:59 PM AEST| By SamHealthcare combines essential demand, demographic support, and innovation. Leading ASX healthcare companies operate across diagnostics, biotechnology, devices, and digital healthcare.
Healthcare’s Biggest Sell-Off Could Be Creating New Opportunities
June 03, 2026 11:20 AM AEST| By SamHealthcare remains one of the weakest-performing sectors this year, with major companies facing pressure despite ongoing operational and industry developments.
AI Fear or Hidden Strength? Why Pro Medicus Is Back in Focus
June 03, 2026 10:23 AM AEST| By SamPro Medicus continues attracting attention as artificial intelligence transforms healthcare technology. Recent contract developments suggest AI may enhance the company's imaging platform rather than disrupt its long-term position.
Why Ramsay Health Care Remains A Key Healthcare Stock To Watch
June 03, 2026 10:06 AM AEST| By SamRamsay Health Care remains a closely watched healthcare operator as market participants assess private hospital demand, sector trends and broader economic conditions.
Is Micro-X Approaching a Defining Moment in Healthcare Technology?
June 03, 2026 09:42 AM AEST| By SamMicro-X is attracting attention through its specialised imaging technology, expanding commercial activities, and debt-free balance sheet as it advances across healthcare, defence and security markets.
Why Do ASX Healthcare Stocks Command Attention?
June 03, 2026 01:10 AM AEST| By SamExplore ASX healthcare stocks, leading medical technology and biotechnology companies, and the factors that make Australia’s healthcare sector globally recognised.
Leading Healthcare Stocks Across the ASX 200 Sector
June 03, 2026 01:06 AM AEST| By SamExplore major ASX healthcare stocks operating across biotechnology, medical devices, diagnostics, healthcare software, hospital management, and pharmaceutical distribution networks.
Healthcare Stocks Across ASX 300 Draw Fresh Interest
June 03, 2026 12:57 AM AEST| By SamAustralia's healthcare sector remains in focus as CSL, ResMed, Cochlear, Pro Medicus, and Sonic Healthcare continue expanding across biotechnology, diagnostics, and medical technology.
Cochlear’s Innovation Focus Remains in Spotlight Despite Operational Challenges
June 02, 2026 11:42 AM AEST| By SamHighlights,Cochlear continues advancing MRI-compatible hearing implant technology.,Hospital capacity constraints and currency headwinds have weighed on recent performance.,Long-term growth outlook remains tied to expanding demand for implantable hear...
Advertise your brand on Kalkine Media